Bristol-Myers Squibb & Gilead Sciences LLC v. Canada (Health), 2013 FC 1271

Date: 20131220

Docket: T-280-12

Citation: 2013 FC 1271

Ottawa, Ontario, December 20, 2013

PRESENT:    The Honourable Mr. Justice Barnes

BETWEEN:

           REASONS FOR JUDGMENT AND JUDGMENT

[1]               For the Reasons given in Federal Court file T-8-12, citation 2013 FC 1270 this application is similarly decided. 

JUDGMENT

THIS COURT’S JUDGMENT is that: 

a)                  The application is allowed in part;

b)                  The Minister is prohibited from issuing a Notice of Compliance to Teva in respect of its tenofovir disoproxil fumarate product until the expiry of Canadian Letters Patent 2, 261,619; and

c)                  The issue of costs is reserved pending further written submissions from the parties. 

"R.L. Barnes"

FEDERAL COURT

SOLICITORS OF RECORD

DOCKET:                                         T-280-12

STYLE OF CAUSE:                        BRISTOL-MYERS SQUIBB & GILEAD SCIENCES LLC ET AL v THE MINISTER OF HEALTH ET AL

PLACE OF HEARING:                  Toronto, ON

DATE OF HEARING:                    September 9 to 16, 2013

REASONS FOR JUDGMENT:      BARNES J.

DATED:                                            December 20, 2013

APPEARANCES:

SOLICITORS OF RECORD: